Home

Keith J Nelsen

CIK 1521145 · GC & CORPORATE SECRETARY · last filed 2021-12-16

Keith J Nelsen is a GC & CORPORATE SECRETARY who has filed 57 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing, for BHG, was dated Dec 16, 2021. Across all open-market trades the lifetime net is −$21.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.8M across reported positions. 62 SEC filings were submitted jointly with BEST BUY CO INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.81M

Companies

2

Total Filings

57

Lifetime Open-Market Net

-$21.42M

Filer Profile

Reported Address
7601 PENN AVENUE SOUTH
RICHFIELD, MN 55423
Related Filers
BEST BUY CO INC — 62 joint filings, latest 2019-03-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NeueHealth, Inc. (BHG) Delisted GC & CORPORATE SECRETARY 5,625 $16.35 $92.0K $0 2 2021-12-16
BBY General Counsel & Secreta 111,377 $88.09 $9.81M -$21.42M 55 2019-03-18

Recent Filings

57 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-12-16 NeueHealth, Inc. (BHG) Delisted Grant (A) — $0 EDGAR
2021-06-30 NeueHealth, Inc. (BHG) Delisted Mixed +450,000 $797.9K EDGAR
2019-03-18 BBY Sell (S) −24,374 -$1.67M EDGAR
2019-03-13 BBY Grant (A) +50,543 $0 EDGAR
2018-09-06 BBY Mixed −18,949 -$2.10M EDGAR
2018-03-19 BBY Sell (S) −13,003 -$902.9K EDGAR
2018-03-15 BBY Sell (S) −2,022 -$142.5K EDGAR
2018-03-14 BBY Mixed +18,105 -$103.4K EDGAR
2018-03-05 BBY Grant (A) +19,528 $0 EDGAR
2017-11-24 BBY Mixed — -$871.0K EDGAR
Showing 1–10 of 57
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.